arXiv subjects

Samira Nedungadi

Publications and source records attributed to Samira Nedungadi.

5 recordsLinked to original sources

arXiv2026

Agentic BAIM-LLM Evaluation (ABLE): Benchmarking LLM Use of Protein Design Tools

We introduce ABLE, a benchmark for evaluating LLM agents' ability to use biological AI models (BAIMs), such as ProteinMPNN and AlphaFold3, in dual-use protein design workflows. ABLE assesses agent performance through a set of tasks spanning structure retrieval, sequence generation, and design validation. We evaluate 15 frontier models and find that seven refuse all tasks, while the remaining models exhibit substantial performance differences. Claude Sonnet 4 and Gemini 3 Pro achieve the highest scores across information retrieval, tool selection, and tool use. We further compare model performance on a subset of tasks against an expert human baseline. Our results suggest that current LLMs can substantially lower barriers to protein design, but remain inconsistent in planning, strategy generation, and integrating biological knowledge with tool use.

cs.AI↗

arXiv2026

ABC-Bench: An Agentic Bio-Capabilities Benchmark for Biosecurity

Large language models (LLMs) are rapidly acquiring capabilities relevant to biological research, from literature synthesis to interpretation of experimental data. Increasingly, LLM agents can also perform in silico biology tasks that previously required experienced human biologists. These emerging AI capabilities offer new opportunities for scientific discovery and biomedical advances, but they also shift the landscape of biosecurity risks. To address this, we introduce the Agentic Bio-Capabilities Benchmark (ABC-Bench), a suite of tasks to measure agentic biosecurity-relevant capabilities. ABC-Bench evaluates LLM agents on both benign and dual-use biology tasks: writing code to operate liquid handling robots, designing DNA fragments for in vitro assembly, and evading DNA synthesis screening. These tasks require a combination of biology and software expertise. All tested LLM agents outperformed the median expert human baseliner on all three tasks. Agents performed highly on tasks drawing on published knowledge and well-documented protocols, and more weakly on a task requiring novel bioinformatics reasoning. In three wet-lab validation experiments, we found that OpenAI's o4-mini-high produced scripts that, when run on an OpenTrons liquid handling robot, successfully assembled DNA with expected sequences.

cs.AI↗

arXiv2026

LLM Novice Uplift on Dual-Use, In Silico Biology Tasks

Large language models (LLMs) perform increasingly well on biology benchmarks, but it remains unclear whether they uplift novice users -- i.e., enable humans to perform better than with internet-only resources. This uncertainty is central to understanding both scientific acceleration and dual-use risk. We conducted a multi-model, multi-benchmark human uplift study comparing novices with LLM access versus internet-only access across eight biosecurity-relevant task sets. Participants worked on complex problems with ample time (up to 13 hours for the most involved tasks). We found that LLM access provided substantial uplift: novices with LLMs were 4.16 times more accurate than controls (95% CI [2.63, 6.87]). On four benchmarks with available expert baselines (internet-only), novices with LLMs outperformed experts on three of them. Perhaps surprisingly, standalone LLMs often exceeded LLM-assisted novices, indicating that users were not eliciting the strongest available contributions from the LLMs. Most participants (89.6%) reported little difficulty obtaining dual-use-relevant information despite safeguards. Overall, LLMs substantially uplift novices on biological tasks previously reserved for trained practitioners, underscoring the need for sustained, interactive uplift evaluations alongside traditional benchmarks.

cs.AI↗

arXiv2025

Best Practices for Biorisk Evaluations on Open-Weight Bio-Foundation Models

Open-weight bio-foundation models present a dual-use dilemma. While holding great promise for accelerating scientific research and drug development, they could also enable bad actors to develop more deadly bioweapons. To mitigate the risk posed by these models, current approaches focus on filtering biohazardous data during pre-training. However, the effectiveness of such an approach remains unclear, particularly against determined actors who might fine-tune these models for malicious use. To address this gap, we propose BioRiskEval, a framework to evaluate the robustness of procedures that are intended to reduce the dual-use capabilities of bio-foundation models. BioRiskEval assesses models' virus understanding through three lenses, including sequence modeling, mutational effects prediction, and virulence prediction. Our results show that current filtering practices may not be particularly effective: Excluded knowledge can be rapidly recovered in some cases via fine-tuning, and exhibits broader generalizability in sequence modeling. Furthermore, dual-use signals may already reside in the pretrained representations, and can be elicited via simple linear probing. These findings highlight the challenges of data filtering as a standalone procedure, underscoring the need for further research into robust safety and security strategies for open-weight bio-foundation models.

cs.CR↗

arXiv2025

STREAM (ChemBio): A Standard for Transparently Reporting Evaluations in AI Model Reports

Evaluations of dangerous AI capabilities are important for managing catastrophic risks. Public transparency into these evaluations - including what they test, how they are conducted, and how their results inform decisions - is crucial for building trust in AI development. We propose STREAM (A Standard for Transparently Reporting Evaluations in AI Model Reports), a standard to improve how model reports disclose evaluation results, initially focusing on chemical and biological (ChemBio) benchmarks. Developed in consultation with 23 experts across government, civil society, academia, and frontier AI companies, this standard is designed to (1) be a practical resource to help AI developers present evaluation results more clearly, and (2) help third parties identify whether model reports provide sufficient detail to assess the rigor of the ChemBio evaluations. We concretely demonstrate our proposed best practices with "gold standard" examples, and also provide a three-page reporting template to enable AI developers to implement our recommendations more easily.

cs.CY↗